Experimental Evidence of Dexamethasone in Reversing Endothelial Dysfunction in COVID-19: Therapeutic Insights from Intranasal Administration
- DOI
- 10.1016/j.clinthera.2025.11.005
- Published
- 2026-01
- Container
- Clinical Therapeutics
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.clinthera.2025.11.005,
title = {Experimental Evidence of Dexamethasone in Reversing Endothelial Dysfunction in COVID-19: Therapeutic Insights from Intranasal Administration},
author = {Celeste Trejo-Moreno and Marisol Méndez-Martínez and Zimri A. Alvarado-Ojeda and Sergio Sifontes-Rodríguez and Jaquelynne Cervantes-Torres and Raul J. Bobes and Juan P. Laclette and Edda Sciutto and Gladis Fragoso and Gabriela Rosas-Salgado},
year = {2026},
journal = {Clinical Therapeutics},
doi = {10.1016/j.clinthera.2025.11.005},
url = {https://doi.org/10.1016/j.clinthera.2025.11.005}
}RIS
TY - JOUR TI - Experimental Evidence of Dexamethasone in Reversing Endothelial Dysfunction in COVID-19: Therapeutic Insights from Intranasal Administration AU - Celeste Trejo-Moreno AU - Marisol Méndez-Martínez AU - Zimri A. Alvarado-Ojeda AU - Sergio Sifontes-Rodríguez AU - Jaquelynne Cervantes-Torres AU - Raul J. Bobes AU - Juan P. Laclette AU - Edda Sciutto AU - Gladis Fragoso AU - Gabriela Rosas-Salgado PY - 2026 JO - Clinical Therapeutics DO - 10.1016/j.clinthera.2025.11.005 UR - https://doi.org/10.1016/j.clinthera.2025.11.005 ER -
APA
Trejo-Moreno, C., Méndez-Martínez, M., Alvarado-Ojeda, Z. A., Sifontes-Rodríguez, S., Cervantes-Torres, J., Bobes, R. J., Laclette, J. P., Sciutto, E., Fragoso, G., & Rosas-Salgado, G. (2026). Experimental Evidence of Dexamethasone in Reversing Endothelial Dysfunction in COVID-19: Therapeutic Insights from Intranasal Administration. Clinical Therapeutics. https://doi.org/10.1016/j.clinthera.2025.11.005
Source records
- crossref · retrieved 2026-09-26T20:51:37.242Z